EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

Journal of Diabetes Investigation

ISSN 2040-1116 · Wiley

Latest articles

  1. Efficacy and safety of teneligliptin as add‐on therapy in patients with type 2 diabetes treated with empagliflozin and metformin: A 24‐week, randomized, double‐blind, placebo‐controlled phase 3 trial

    Soo Heon Kwak, KyungWan Min, Bon Jeong Ku, Ji A Seo, Sang Yong Kim, Sang Youl Rhee, Gyuri Kim, Jae Hyoung Cho, Sang‐Ah Chang, Sung Hee Choi, Seung Jin Han, Jeong Hyun Park, Kyu Jeung Ahn, Chul Woo Ahn, Bong‐Soo Cha, Hye Soon Kim, Joo Young Nam, Heung Yong Jin, Hyuk‐Sang Kwon, Sin Gon Kim, Sang Soo Kim, Jun Sung Moon, Kang Seo Park, BokJin Hyun, SunYoung Kim, Kyong Soo Park

    Published: 2026-11-14DOI: 10.1111/jdi.70491

  2. Development and external validation of machine learning models for predicting glucose trajectories after continuous intravenous insulin therapy in hyperglycemic crises

    Yuichiro Iwamoto, Tomohiko Kimura, Yuichi Morimoto, Hideyuki Iwamoto, Yoshiro Fushimi, Junpei Sanada, Hayato Isobe, Fuminori Tatsumi, Yukiko Kimura, Fumiko Kawasaki, Mizuho Yamabe, Michihiro Matsuki, Kensuke Mohri, Takafumi Osaka, Masashi Shimoda, Shuhei Nakanishi, Kohei Kaku, Hideaki Kaneto

    Published: 2026-11-11DOI: 10.1111/jdi.70489

  3. Influence of age on the development of stress hyperglycemia during first‐onset ST ‐elevation myocardial infarction

    Hon Jen Wong, Joy Xin Yi Au, Yao Hao Teo, Yao Neng Teo, Chen Ee Low, Chun En Yau, Norman H.Y. Lin, Pei Chia Eng, Li Feng Tan, Reshma A. Merchant, Ping Chai, Anand Adinath Ambhore, James W. L. Yip, Andrew Fu‐Wah Ho, David Foo, Pow‐Li Chia, Patrick Zhan‐Yun Lim, Khung Keong Yeo, Weien Chow, Daniel Thuan Tee Chong, Derek J. Hausenloy, Mark Y. Y. Chan, Ching‐Hui Sia

    Published: 2026-11DOI: 10.1111/jdi.70429

Volumes

2026 · 3042025 · 2822024 · 2232023 · 1872022 · 2652021 · 3022020 · 2312019 · 2202018 · 2012017 · 1262016 · 1672015 · 1192014 · 1242013 · 1082012 · 992011 · 892010 · 62

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.